| S.No. | Code | Description |
| 1 |
B088
| FIBRINOGEN, CLOTTING ACTIVITY |
| 2 |
B100
| HAPTOGLOBIN |
| 3 |
E016
| ACTIVATED PROTEIN C-RESISTANCE; APCR |
| 4 |
H012
| OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST |
| 5 |
H014
| PARTIAL THROMBOPLASTIN TIME, ACTIVATED; PTT; APTT |
| 6 |
H015
| BLEEDING TIME; BT |
| 7 |
H016
| CLOTTING TIME; CT |
| 8 |
H026
| FIBRINOGEN DEGRADATION PRODUCTS ( FDP), BLOOD |
| 9 |
H028
| COOMBS TEST, DIRECT |
| 10 |
H037
| CLOT RETRACTION TEST |
| 11 |
H038
| THROMBIN TIME; TT |
| 12 |
H041
| FACTOR XIII ( CLOT SOLUBILITY),FUNCTIONAL, QUALITATIVE |
| 13 |
H042
| SICKLING, SCREENING TEST |
| 14 |
H046
| ANTI A TITRE |
| 15 |
H047
| ANTI B TITRE |
| 16 |
H050
| LEUCOCYTE ALKALINE PHOSPHATASE SCORE; LAP SCORE |
| 17 |
H051
| ABSOLUTE NEUTROPHIL COUNT |
| 18 |
H052
| ABSOLUTE LYMPHOCYTE COUNT |
| 19 |
H060
| FERRITIN |
| 20 |
H061
| PROTEIN C, FUNCTIONAL |
| 21 |
H101
| ANTITHROMBIN III, FUNCTIONAL |
| 22 |
H119
| HAM TEST; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), SCREENING TEST |
| 23 |
H124
| PARTIAL THROMBOPLASTIN TIME - LUPUS ANTICOAGULANT SPECIFIC; PTT - LA |
| 24 |
H128
| TRANSFERRIN |
| 25 |
H130
| von WILLEBRAND FACTOR ANTIGEN; vWF Ag |
| 26 |
H131
| PROTHROMBIN TIME STUDIES *Prothrombin Time (PT) *Prothrombin Ratio (PR) *International Normalised Ratio (INR) |
| 27 |
H134
| D - DIMER, QUANTITATIVE |
| 28 |
H173
| FACTOR II, FUNCTIONAL |
| 29 |
H174
| FACTOR V, FUNCTIONAL |
| 30 |
H175
| FACTOR IX, FUNCTIONAL |
| 31 |
H176
| FACTOR X, FUNCTIONAL |
| 32 |
H177
| FACTOR XI, FUNCTIONAL |
| 33 |
H178
| FACTOR VII FUNCTIONAL |
| 34 |
H179
| FACTOR XII, FUNCTIONAL |
| 35 |
H180
| PROTEIN S, FUNCTIONAL |
| 36 |
H184
| PARTIAL THROMBOPLASTIN TIME - ACTIVATED, MIXING STUDIES; APTT MIXING STUDIES *Fibrinogen *TT *APTT *Mixing studies |
| 37 |
H204
| HEINZ BODIES, PERIPHERAL BLOOD |
| 38 |
H209
| FACTOR V LEIDEN MUTATION ANALYSIS *Factor V Leiden Mutation * Prothrombin Gene Mutation * MTHFR Gene Mutation |
| 39 |
H224
| PAS ( PERIODIC ACID SCHIFF) STAIN, BLOOD / BONE MARROW |
| 40 |
H225
| MYELOPEROXIDASE (MPO) STAIN, BLOOD / BONE MARROW |
| 41 |
H226
| SUDAN BLACK B STAIN, BLOOD / BONE MARROW |
| 42 |
H227
| BONE MARROW, IRON STAIN |
| 43 |
H228
| ZAP - 70 ( Marker for CLL) |
| 44 |
H229
| CD 138 ( Plasma cell marker) |
| 45 |
H230
| CD 36 ( Monocytic, Erythroid, Megakaryocytic marker) |
| 46 |
H231
| CD 64 ( Monocytic, Intermediate Neutrophil Precursor marker ) |
| 47 |
H232
| CD123 ( Erythroid, Monocytic & Megakaryocytic marker ) |
| 48 |
J150
| IMMUNOHISTOCHEMISTRY - ANY 3 MARKERS |
| 49 |
J151
| IMMUNOHISTOCHEMISTRY - ANY 5 MARKERS |
| 50 |
N018
| VENOUS THROMBOSIS RISK ANALYSIS, PROFILE *Factor V Leiden Mutation * Prothrombin Gene Mutation * MTHFR Gene Mutation |
| 51 |
N024
| HLA DNA TYPING FOR BONE MARROW TRANSPLANT, PCR *A, B, C, DR & DQ Typing |
| 52 |
N035
| BCR-ABL PCR Quantitative |
| 53 |
N037
| BCR-ABL PCR Qualitative |
| 54 |
N038
| PML-RARA QUALITATIVE |
| 55 |
N039
| JAK -2 Qualitative PCR |
| 56 |
N044
| HLA - B27, PCR |
| 57 |
N045
| AML ETO t( 8;21) GENE REARRANGEMENT, PCR QUALITATIVE |
| 58 |
N046
| INV 16 ( p13q22) / t( 16;16)(p13;q22) GENE REARRANGEMENT, PCR QUALITATIVE |
| 59 |
Q005
| CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY |
| 60 |
Q016
| CHROMOSOME ANALYSIS, PHILADELPHIA |
| 61 |
R018
| ERYTHROPOIETIN; EPO |
| 62 |
R046
| FOLATE (FOLIC ACID), SERUM |
| 63 |
R048
| FOLATE (FOLIC ACID), RBC Includes Serum Folate. |
| 64 |
RW006
| ALPHA-1-ACID GLYCOPROTEIN |
| 65 |
RW016
| ANTITHROMBIN III, ANTIGENIC |
| 66 |
RW077
| GANGLIOSIDE GD1b ANTIBODY, IgG |
| 67 |
RW110
| IMMUNOGLOBULIN IgM, CSF |
| 68 |
RW120
| LEGIONELLA PNEUMOPHILA IgM, IFA |
| 69 |
RW121
| LEGIONELLA URINARY ANTIGEN, EIA |
| 70 |
RW141
| NUCLEAR MATRIX PROTEINS; NMP |
| 71 |
RW172
| SACCHAROMYCES CEREVISIAE ANTI BODY, IgG (CROHN'S DISEASE ); ASCA IgG |
| 72 |
RW176
| T3 ANTIBODY |
| 73 |
RW185
| THYROTROPIN RELEASING HORMONE; TRH |
| 74 |
RW186
| TOXICOLOGY SCREEN, BLOOD |
| 75 |
RW199
| VITAMIN B1 (THIAMINE), WHOLE BLOOD |
| 76 |
U046
| HEMOSIDERIN, URINE |
| 77 |
U047
| HEMOGLOBIN, FREE, URINE |
| 78 |
XX010
| BMT sex mismatch, XY probe |
| 79 |
Z041
| COAGULATION PROFILE 2 *Coagulation Profile 1 *Factor VIII assay |
| 80 |
Z042
| COAGULATION PROFILE 1 *CBC *BT *CT *Prothrombin studies *APTT*Thrombin Time. Does not include Factor VIII assay |
| 81 |
Z049
| THALASSEMIA PROFILE *Iron Studies *Complete Blood Count *Hemoglobin HPLC/Electrophoresis |
| 82 |
Z051
| FACTOR VIII STUDIES *Factor VIII Assay *APTT |
| 83 |
Z125
| FOLATE & VITAMIN B12, SERUM |
| 84 |
Z146
| IMMUNE DEFICIENCY PANEL 1 * CD3 * CD4 * CD8 * CD19 * CD16+/CD56. Includes % and Absolute Counts. |
| 85 |
Z147
| CD 8 (Suppressor T cell marker) |
| 86 |
Z148
| IMMUNE DEFICIENCY PANEL 3; ABSOLUTE CD 3 COUNT. Includes % and Absolute Counts. |
| 87 |
Z168
| LUPUS ANTICOAGULANT PANEL; LAC PANEL *APTT *PTT - LA *dRVVT |
| 88 |
Z219
| CD 4 (Helper T cell marker) |
| 89 |
Z220
| IMMUNE DEFICIENCY PANEL 5 *CD3 * CD19. Includes % and Absolute Counts. |
| 90 |
Z319
| THROMBOPHILIA PROFILE *Protein C, Functional *Protein S, Functional *Antithrombin III, Functional *Factor V Leiden |
| 91 |
Z374
| HEMOPHILIA PANEL *APTT *Factor VIII *Factor IX |
| 92 |
Z476
| BONE MARROW ASPIRATE EXAMINATION PANEL 1 * Microscopy of Bone Marrow & Peripheral Blood* Special Stains * CBC |
| 93 |
Z477
| BONE MARROW ASPIRATE EXAMINATION PANEL 2 * Bone Marrow Aspirate Examination Panel 1 * Histopathology |
| 94 |
Z496
| CD 55 & 59 (PNH markers) |
| 95 |
Z497
| THROMBOPHILIA COMPREHENSIVE PROFILE *Thrombophilia profile *Lupus anticoagulant |
| 96 |
Z499
| BONE MARROW, TREPHINE BIOPSY PANEL * Histopathology * Reticulin stain * Iron stain |
| 97 |
Z512
| LEUKEMIA DIAGNOSTIC PANEL, CUSTOMIZED (ANY 10 MARKERS) |
